Wellington, NZ, 3rd March 2017: Volpara Health Technologies (“Volpara”; ASX:VHT), a digital health company focused on early detection of breast cancer by improving quality of screening, has today released an updated investor presentation ahead of a series of meetings to be held in Sydney, Melbourne and Brisbane during March.
The presentation provides an update on contracts signed in January and February 2017. As of 28th February 2017, the company had nine signed VolparaEnterpriseTM software-as-a- service (SaaS) contracts, adding three new customers since the start of the calendar year, along with several capital deals.
To view Presentation please download PDF attached:
Download this document
